Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Company
Bayer to strengthen its presence in China2010-12-09
Sumitomo bought equity in C&O2010-12-06
Cardinal acquires Chinese distributor for $470 mn2010-12-01
Xunda to built 1000 tons Phosphonomycin project2010-11-30
Sihuan to acquire Dupromise for RMB 2.4 bln2010-11-29
Mudanjiang began to export bulk VC2010-11-25
Shuzhong Pharma expanded its Cefipime facility2010-11-24
Haoyun's project of Cephalosporins intermediates into production2010-11-24
APIs project of Sihuan Gaobo into production2010-11-23
North Pharm to produce Vitamin C and Penicillin G soon2010-11-22
Zhejiang Garden stopped shipment of Vitamin D32010-11-19
NEPC resumed VC production2010-11-18
Duowei Pharma intended to invest on Ceftriaxone project2010-11-16
Haoyun to build a project of 1000 ton Cephalosporins intermediates2010-11-16
Novo Nordisk invested 100 mln USD to expand its R&D center2010-11-15
Ningxia Pacific building 15000 tons Erythromycin project2010-11-09
Eli Lilly plans diabetes-focused research centre in China2010-11-09
United Laboratories to raise price for Amoxicillin and 6-APA2010-11-05
Hisound resumes exporting Vitamin D32010-11-04
Nycomed to acquire majority stake in Techpool2010-11-03
Sanofi expanded presence in China through acquisition2010-11-01
North China Pharma will produce Cephalosporines formula2010-10-27
Roche formally launched Avastin in China2010-10-26
Topfond raised quoted price for Lincomycin2010-10-25
Zhejiang Yatai will soon formally produce bulk Azithromycin2010-10-22
Nanhai Baisha started Vitamin E project in Jilin2010-10-22
Tiger's food grade Vitamin C gets production license2010-10-21
Hanson Pharma got GMP certification2010-10-20
Herbalife built large scale production base in Changsha2010-10-19
Jiuzhoutong group to launch IPO in Oct.2010-10-19
Ruiying Pharma got cGMP certification from FDA2010-10-18
Yatai Pharma got certificate for Roxithromycin2010-10-15
共2619个 页次:67/82页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463